InBios' Lyme Detect™ Multiplex ELISA Demonstrates Potential to Streamline Lyme Disease Testing in New UConn Health Study

positiveLyme Detect™ Multiplex ELISAPositive

AI Analysis

Summary

InBios International's Lyme Detect™ Multiplex ELISA has demonstrated potential to streamline Lyme disease testing in a UConn Health study showing that a single-step ELISA approach can improve testing efficiency.

Outcome Details

Study demonstrates single-step ELISA approach can streamline Lyme disease testing

Importance:4/10

Sentiment:

0.60

diagnosticsLyme diseaseELISAinfectious diseasesstudy results

Related Companies

$ISCO

Read the original article

Published by PR Newswire Biotech on September 17, 2026 7:00 AM

Read Original